Cancer Prevention & Online Technologies

NCT ID: NCT04064424

Last Updated: 2024-12-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

720000 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-12-31

Study Completion Date

2026-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The overall goal of this research is to develop interventions that leverage online technology (e.g. ads, social media) to reduce individuals' skin-cancer-related risk behaviors and ultimately to reduce skin cancer incidence.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This research includes three phases:

1. To better understand the motivators and inhibitors of skin cancer risk behaviors in various populations including use of indoor tanning and outdoor sun exposure;
2. To develop content messages and images related to skin cancer risk that are resonant with various populations;
3. To test the relative effectiveness of these messages in reducing likelihood of or actual skin cancer risk behaviors in various populations.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Skin Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Prevention Advertisement

Participants will be exposed to prevention videos and images through Facebook Advertising

Group Type EXPERIMENTAL

Prevention video advertisement

Intervention Type OTHER

Skin Cancer Prevention videos

Prevention images for advertisement

Intervention Type OTHER

Skin Cancer Prevention images

No Advertisement

No prevention videos and images will be shown through Facebook Advertising

Group Type ACTIVE_COMPARATOR

No Advertisement

Intervention Type OTHER

No skin cancer prevention videos or images were advertised.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Prevention video advertisement

Skin Cancer Prevention videos

Intervention Type OTHER

Prevention images for advertisement

Skin Cancer Prevention images

Intervention Type OTHER

No Advertisement

No skin cancer prevention videos or images were advertised.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Facebook user between the age of 18 and 65
* Self-identifies as male
* Profile indicates interest in at least one of the following: LGBT community, LGBT culture, LGBT social movements, Rainbow flag, Gay pride, GAY-friendly, homosexuality
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Cancer Institute (NCI)

NIH

Sponsor Role collaborator

Stanford University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Eleni Linos

Role: PRINCIPAL_INVESTIGATOR

Stanford University

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Lily Morrison

Role: CONTACT

Phone: 650-723-6109

Email: [email protected]

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

IRB-50303

Identifier Type: OTHER

Identifier Source: secondary_id

SKIN0049

Identifier Type: OTHER

Identifier Source: secondary_id

1DP2CA225433-01

Identifier Type: NIH

Identifier Source: secondary_id

View Link

IRB-50303

Identifier Type: -

Identifier Source: org_study_id